Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
292
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
SK Bioscience
•
07 Feb 2021 02:23
SK Bioscience IPO Preview - Biggest IPO in Korea in 1Q 2021
SK Bioscience is getting ready to complete its IPO in Korea in March. SK Bioscience will be the biggest IPO in Korea so far this year in 2021. The...
Douglas Kim
Follow
410 Views
Share
bearish
•
Celltrion Inc
•
03 Feb 2021 14:26
Korea Short Sell Ban: Elections, Public Outrage, Bus Tours, Blue House Petitions, K-Streetbets
With the short sell ban in Korea scheduled to expire 15 March, we look at stocks that have seen the most short covering since the start of the ban,...
Brian Freitas
Follow
400 Views
Share
bullish
•
Quantitative Analysis
•
30 Jan 2021 05:58
Asia Short Interest: BYD, Smoore, GCL Poly, Olympus, Nomura, Anritsu, Netmarble, UMC, Innolux, Acer
The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...
Brian Freitas
Follow
286 Views
Share
bullish
•
Samsung Electronics
•
20 Jan 2021 01:36
JY Lee & The Ides of March.....and What It Means for You
The impact of the JY Lee jail sentencing and what it means for Samsung Electronics, Samsung C&T and its affiliates down the line.
Ken S. Kim
Follow
291 Views
Share
bullish
•
Samsung C&T
•
15 Jan 2021 01:46
Samsung C&T: Valuation Sensitivity Analysis & Key Catalysts
We provide an updated valuation of Samsung C&T and key catalysts of the company. Our base case valuation of Samsung C&T is implied price of 231,387...
Douglas Kim
Follow
440 Views
Share
First
Previous
21
22
23
24
25
26
27
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x